These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

798 related articles for article (PubMed ID: 23702337)

  • 61. Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System.
    Mehta SJ; Jensen CD; Quinn VP; Schottinger JE; Zauber AG; Meester R; Laiyemo AO; Fedewa S; Goodman M; Fletcher RH; Levin TR; Corley DA; Doubeni CA
    J Gen Intern Med; 2016 Nov; 31(11):1323-1330. PubMed ID: 27412426
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of faecal occult blood test screening on emergency admissions and short-term outcomes for colorectal cancer.
    Libby G; Brewster DH; Steele RJ
    Br J Surg; 2014 Nov; 101(12):1607-15. PubMed ID: 25219923
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Colorectal cancer prevention in the Czech Republic: time trends in performance indicators and current situation after 10 years of screening.
    Suchanek S; Majek O; Vojtechova G; Minarikova P; Rotnaglova B; Seifert B; Minarik M; Kozeny P; Dusek L; Zavoral M
    Eur J Cancer Prev; 2014 Jan; 23(1):18-26. PubMed ID: 24129196
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Differences in colorectal cancer screening rates across income strata by levels of urbanization: results from the Canadian Community Health Survey (2013/2014).
    Simkin J; Ogilvie G; Hanley B; Elliott C
    Can J Public Health; 2019 Feb; 110(1):62-71. PubMed ID: 30353502
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Socioeconomic and ethnic inequities within organised colorectal cancer screening programmes worldwide.
    de Klerk CM; Gupta S; Dekker E; Essink-Bot ML;
    Gut; 2018 Apr; 67(4):679-687. PubMed ID: 28073892
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Participation in colorectal cancer screening: a review.
    Vernon SW
    J Natl Cancer Inst; 1997 Oct; 89(19):1406-22. PubMed ID: 9326910
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fecal occult blood testing: people in Ontario are unaware of it and not ready for it.
    Ritvo P; Myers R; Del Giudice ME; Pazsat L; Cotterchio M; Howlett R; Mai V; Brown P; Sullivan T; Rabeneck L
    Can Fam Physician; 2009 Feb; 55(2):176-177.e4. PubMed ID: 19221081
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact on immigrant screening adherence with introduction of a population-based colon screening program in Ontario, Canada.
    Moustaqim-Barrette A; Spinelli JJ; Kazanjian A; Dummer TJB
    Cancer Med; 2019 Apr; 8(4):1826-1834. PubMed ID: 30791219
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Interval colorectal cancer rates after Hemoccult Sensa and survival by detection mode for individuals diagnosed with colorectal cancer in Winnipeg, Manitoba.
    Decker KM; Nugent Z; Lambert P; Biswanger N; Singh H
    PLoS One; 2018; 13(9):e0203321. PubMed ID: 30180176
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Colorectal cancers detected through screening are associated with lower stages and improved survival.
    Lindebjerg J; Osler M; Bisgaard C
    Dan Med J; 2014 Jan; 61(1):A4758. PubMed ID: 24393588
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Predictors of non-adherence to colorectal cancer screening among immigrants to Ontario, Canada: a population-based study.
    Shen SC; Lofters A; Tinmouth J; Paszat L; Rabeneck L; Glazier RH
    Prev Med; 2018 Jun; 111():180-189. PubMed ID: 29548788
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Impact of a Population-Based Screening Program on Income- and Immigration-Related Disparities in Colorectal Cancer Screening.
    Kiran T; Glazier RH; Moineddin R; Gu S; Wilton AS; Paszat L
    Cancer Epidemiol Biomarkers Prev; 2017 Sep; 26(9):1401-1410. PubMed ID: 28626067
    [No Abstract]   [Full Text] [Related]  

  • 73. [Compliance rate of screening colonoscopy and its associated factors among high-risk populations of colorectal cancer in urban China].
    Chen HD; Li N; Ren JS; Shi JF; Zhang YM; Zou SM; Zheng ZX; Zhang K; Dai M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Mar; 52(3):231-237. PubMed ID: 29973000
    [No Abstract]   [Full Text] [Related]  

  • 74. [Organized colorectal cancer screening].
    Rouëssé J; Sancho-Garnier H;
    Bull Acad Natl Med; 2014 Feb; 198(2):387-99. PubMed ID: 26263711
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Racial and ethnic disparities in colorectal cancer screening persisted despite expansion of Medicare's screening reimbursement.
    White A; Vernon SW; Franzini L; Du XL
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):811-7. PubMed ID: 21546366
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Physician-office vs home uptake of colorectal cancer screening using FOBT/FIT among screening-eligible US adults.
    Chido-Amajuoyi OG; Sharma A; Talluri R; Tami-Maury I; Shete S
    Cancer Med; 2019 Dec; 8(17):7408-7418. PubMed ID: 31637870
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The fecal occult blood test as a tool for improved outpatient qualification for colonoscopy. A single-center experience and 10-year follow-up survey.
    Banaszkiewicz Z; Budzyński J; Tojek K; Jarmocik P; Frasz J; Mrozowski M; Świtoński M; Jawień A
    Adv Med Sci; 2017 Mar; 62(1):171-176. PubMed ID: 28282604
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Changes in colorectal cancer screening use after introduction of alternative screening offer in Germany: Prospective cohort study.
    Guo F; Chen C; Schöttker B; Holleczek B; Hoffmeister M; Brenner H
    Int J Cancer; 2020 May; 146(9):2423-2432. PubMed ID: 31291471
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Screening rates for colorectal cancer in Canada: a cross-sectional study.
    Singh H; Bernstein CN; Samadder JN; Ahmed R
    CMAJ Open; 2015; 3(2):E149-57. PubMed ID: 26389092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.